pharmaceutical investing Boehringer Ingelheim and Lilly announce positive top-line Phase III data results for empagliflozin as adjunct to insulin in type 1 diabetes
American Eagle Continues to Expand South Zone near Surface Mineralization: Highlights Include 140 m of 0.74% Copper Eq. and 130 m of 0.62% Copper Eq.
